[CBPO] China Biologic Products, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 111.28 Change: 0.93 (0.84%)
Ext. hours: Change: 0 (0%)

chart CBPO

Refresh chart

Strongest Trends Summary For CBPO

CBPO is in the medium-term up 28% in 5 months. In the long-term up 57% in 1 year and up 1996% in 16 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: China Biologic Products, Inc., a biopharmaceutical company, is engaged in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers. It offers human albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also offers human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human albumin and human immunoglobulin for intravenous injection (IVIG) products for original immunoglobulin deficiency, secondary immunoglobulin deficiency, and auto-immune deficiency diseases; and Thymopolypeptides injection for the treatment of original and secondary T-cell deficiency syndromes, auto-immune deficiency diseases, and a range of cell immunity deficiency diseas

Fundamental Ratios
Shares Outstanding EPS4.79 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y64.77% Sales Growth - 4 Quarters 17.11% Sales Growth - Q/Q21.33% P/E23.04
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA17.23% ROE32.01% ROI
Current Ratio2.51 Quick Ratio1.67 Long Term Debt/Equity Debt Ratio0.52
Gross Margin66.28% Operating Margin45.83% Net Profit Margin29.46% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-2.16 M Cash From Investing Activities-8.47 M Cash From Operating Activities16.54 M Gross Profit45.89 M
Net Profit23.16 M Operating Profit34.75 M Total Assets440 M Total Current Assets308.42 M
Total Current Liabilities122.71 M Total Debt66.3 M Total Liabilities203.14 M Total Revenue70.35 M
Technical Data
High 52 week115.45 Low 52 week60.38 Last close115.45 Last change0.41%
RSI64.01 Average true range0.97 Beta0.43 Volume79.23 K
Simple moving average 20 days1.02% Simple moving average 50 days9.65% Simple moving average 200 days23.94%
Performance Data
Performance Week0.31% Performance Month15.5% Performance Quart23.81% Performance Half19.21%
Performance Year54.78% Performance Year-to-date52.09% Volatility daily2.19% Volatility weekly4.89%
Volatility monthly10.02% Volatility yearly34.72% Relative Volume213.12% Average Volume164.25 K
New High New Low

News

2019-11-15 10:09:21 | The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval

2019-11-13 16:30:00 | China Biologic Reports Financial Results for the Third Quarter of 2019

2019-11-05 19:01:06 | China Biologic Bidder Seeks Over $1 Billion in Financing

2019-11-04 08:30:00 | China Biologic Products to Report Third Quarter 2019 Financial Results

2019-10-24 12:15:19 | Did Hedge Funds Drop The Ball On China Biologic Products Holdings, Inc. CBPO ?

2019-10-17 08:00:00 | China Biologic Special Committee Retains Financial Advisor and Legal Counsel

2019-10-04 20:00:00 | Tegna, First United, Alico, and Other 13D Filings

2019-09-24 08:00:00 | China Biologic Forms Special Committee to Review _Going Private_ Proposal

2019-09-19 07:39:31 | The Daily Biotech Pulse: China Biologics Receives Buyout Offer, Provention Bio Offering, Exagen IPO

2019-09-19 06:22:00 | China Biologic Shares Soar on Go-Private Takeover Bid

2019-09-18 23:19:40 | UPDATE 1-China Biologic receives offer to be taken private at $120 a share

2019-09-18 17:36:47 | China Biologic receives $4.59 bln take-private buyout offer

2019-09-18 16:01:00 | China Biologic Announces Receipt of Preliminary Non-Binding _Going Private_ Proposal

2019-08-29 17:31:26 | 5 Guru Stocks With Predictable Businesses

2019-08-06 23:23:49 | China Biologic Products Inc CBPO Q2 2019 Earnings Call Transcript

2019-08-06 05:30:00 | China Biologic Products Holdings, Inc. to Host Earnings Call

2019-08-05 16:30:00 | China Biologic Reports Financial Results for the Second Quarter of 2019

2019-07-26 16:30:00 | China Biologic Products to Report Second Quarter 2019 Financial Results

2019-07-09 08:03:09 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-06-18 08:02:31 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-06-13 08:04:13 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-06-11 08:05:09 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-06-10 08:04:52 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-06-04 08:02:30 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-05-13 12:23:11 | China Biologic Products Inc CBPO Q1 2019 Earnings Call Transcript

2019-05-10 17:45:09 | China Biologic Products CBPO Tops Q1 Earnings and Revenue Estimates

2019-05-10 16:41:45 | China Biologic Products: 1Q Earnings Snapshot

2019-05-10 16:30:00 | China Biologic Reports Financial Results for the First Quarter of 2019

2019-05-03 10:30:02 | Earnings Preview: China Biologic Products CBPO Q1 Earnings Expected to Decline

2019-04-30 08:00:00 | China Biologic Products to Report First Quarter 2019 Financial Results

2019-04-27 09:07:02 | Is China Biologic Products Inc CBPO A Good Stock To Buy According To Hedge Funds?

2019-04-26 10:30:02 | Analysts Estimate China Biologic Products CBPO to Report a Decline in Earnings: What to Look Out for

2019-04-09 07:26:11 | New Strong Sell Stocks for April 9th

2019-04-04 09:19:01 | New Strong Sell Stocks for April 4th

2019-04-02 11:51:00 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-03-26 08:21:43 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-03-22 04:10:08 | New Strong Sell Stocks for March 22nd

2019-03-20 07:23:11 | New Strong Sell Stocks for March 20th

2019-03-19 08:30:15 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-03-18 10:47:02 | New Strong Sell Stocks for March 18th

2019-03-12 10:28:12 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-03-07 15:21:43 | China Biologic Products Inc CBPO Q4 2018 Earnings Conference Call Transcript

2019-03-06 17:00:00 | China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2018

2019-02-25 08:00:00 | China Biologic Products to Report Fourth Quarter and Fiscal Year 2018 Financial Results

2019-02-04 13:06:31 | Dalton Investments’ Return, AUM, and Holdings

2019-01-31 08:02:41 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-01-29 08:02:42 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-01-15 08:01:46 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-01-09 08:01:47 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-01-07 08:00:00 | China Biologic Reiterates Full Year 2018 Financial Forecast